Physician profile
Edward R Kusek
NPI 1639101991
$156,207.29
in general payments reported to CMS, 2019-2025
9 companies · $24K in 2025
The $24K reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $20K · 2021: $13K · 2022: $21K · 2023: $13K · 2024: $24K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $49K · Travel and Lodging: $10K · Gift: $782 · Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $49,168.00 |
| Travel and Lodging | $10,489.04 |
| Gift | $781.96 |
| Food and Beverage | $615.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $155,384.33 | 2019-2025 | Opalescence |
| Zimvie INC. | $273.49 | 2023 | |
| Keystone Dental INC. | $126.56 | 2024 | |
| Salvin Dental Specialties, INC. | $106.41 | 2019-2020 | |
| Benco Dental Supply Co. | $98.10 | 2022 | |
| Straumann USA LLC | $68.16 | 2020 | |
| Biohorizons Implant Systems INC. | $64.43 | 2020-2021 | |
| Dentsply Sirona INC | $57.81 | 2019-2021 | |
| Biolase, INC. | $28.00 | 2023 | Waterlase Iplus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Kusek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.